Global 23-valent Pneumococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 96

Published Date: 08 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global 23-valent Pneumococcal Vaccine market size was valued at USD 1481.7 million in 2023 and is forecast to a readjusted size of USD 1977.7 million by 2030 with a CAGR of 4.2% during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the 23-valent Pneumococcal Vaccine industry chain, the market status of Chronic Cardiovascular Disease (Single Dose Vial, Pre-filled Syringe), Chronic Lung Disease (Single Dose Vial, Pre-filled Syringe), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of 23-valent Pneumococcal Vaccine.

Regionally, the report analyzes the 23-valent Pneumococcal Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global 23-valent Pneumococcal Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the 23-valent Pneumococcal Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the 23-valent Pneumococcal Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Single Dose Vial, Pre-filled Syringe).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the 23-valent Pneumococcal Vaccine market.

Regional Analysis: The report involves examining the 23-valent Pneumococcal Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the 23-valent Pneumococcal Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to 23-valent Pneumococcal Vaccine:
Company Analysis: Report covers individual 23-valent Pneumococcal Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards 23-valent Pneumococcal Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Chronic Cardiovascular Disease, Chronic Lung Disease).

Technology Analysis: Report covers specific technologies relevant to 23-valent Pneumococcal Vaccine. It assesses the current state, advancements, and potential future developments in 23-valent Pneumococcal Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the 23-valent Pneumococcal Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
23-valent Pneumococcal Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Single Dose Vial
Pre-filled Syringe

Market segment by Application
Chronic Cardiovascular Disease
Chronic Lung Disease
Chronic Liver Disease
People Living with Hiv
Leukemia
Lymphoma
Multiple Myeloma
General Malignancy
Chronic Kidney Disease
Other

Major players covered
Merck
Sanofipasteur
CDIBP
Kexing Bio
Changsheng Bio-Technology
Huaan Science and Technology Innovation

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 23-valent Pneumococcal Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of 23-valent Pneumococcal Vaccine, with price, sales, revenue and global market share of 23-valent Pneumococcal Vaccine from 2019 to 2024.
Chapter 3, the 23-valent Pneumococcal Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 23-valent Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and 23-valent Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of 23-valent Pneumococcal Vaccine.
Chapter 14 and 15, to describe 23-valent Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of 23-valent Pneumococcal Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global 23-valent Pneumococcal Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Single Dose Vial
        1.3.3 Pre-filled Syringe
    1.4 Market Analysis by Application
        1.4.1 Overview: Global 23-valent Pneumococcal Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Chronic Cardiovascular Disease
        1.4.3 Chronic Lung Disease
        1.4.4 Chronic Liver Disease
        1.4.5 People Living with Hiv
        1.4.6 Leukemia
        1.4.7 Lymphoma
        1.4.8 Multiple Myeloma
        1.4.9 General Malignancy
        1.4.10 Chronic Kidney Disease
        1.4.11 Other
    1.5 Global 23-valent Pneumococcal Vaccine Market Size & Forecast
        1.5.1 Global 23-valent Pneumococcal Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global 23-valent Pneumococcal Vaccine Sales Quantity (2019-2030)
        1.5.3 Global 23-valent Pneumococcal Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck 23-valent Pneumococcal Vaccine Product and Services
        2.1.4 Merck 23-valent Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Merck Recent Developments/Updates
    2.2 Sanofipasteur
        2.2.1 Sanofipasteur Details
        2.2.2 Sanofipasteur Major Business
        2.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Product and Services
        2.2.4 Sanofipasteur 23-valent Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sanofipasteur Recent Developments/Updates
    2.3 CDIBP
        2.3.1 CDIBP Details
        2.3.2 CDIBP Major Business
        2.3.3 CDIBP 23-valent Pneumococcal Vaccine Product and Services
        2.3.4 CDIBP 23-valent Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 CDIBP Recent Developments/Updates
    2.4 Kexing Bio
        2.4.1 Kexing Bio Details
        2.4.2 Kexing Bio Major Business
        2.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Product and Services
        2.4.4 Kexing Bio 23-valent Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Kexing Bio Recent Developments/Updates
    2.5 Changsheng Bio-Technology
        2.5.1 Changsheng Bio-Technology Details
        2.5.2 Changsheng Bio-Technology Major Business
        2.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product and Services
        2.5.4 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Changsheng Bio-Technology Recent Developments/Updates
    2.6 Huaan Science and Technology Innovation
        2.6.1 Huaan Science and Technology Innovation Details
        2.6.2 Huaan Science and Technology Innovation Major Business
        2.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product and Services
        2.6.4 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Huaan Science and Technology Innovation Recent Developments/Updates

3 Competitive Environment: 23-valent Pneumococcal Vaccine by Manufacturer
    3.1 Global 23-valent Pneumococcal Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global 23-valent Pneumococcal Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global 23-valent Pneumococcal Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of 23-valent Pneumococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 23-valent Pneumococcal Vaccine Manufacturer Market Share in 2023
        3.4.2 Top 6 23-valent Pneumococcal Vaccine Manufacturer Market Share in 2023
    3.5 23-valent Pneumococcal Vaccine Market: Overall Company Footprint Analysis
        3.5.1 23-valent Pneumococcal Vaccine Market: Region Footprint
        3.5.2 23-valent Pneumococcal Vaccine Market: Company Product Type Footprint
        3.5.3 23-valent Pneumococcal Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global 23-valent Pneumococcal Vaccine Market Size by Region
        4.1.1 Global 23-valent Pneumococcal Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global 23-valent Pneumococcal Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global 23-valent Pneumococcal Vaccine Average Price by Region (2019-2030)
    4.2 North America 23-valent Pneumococcal Vaccine Consumption Value (2019-2030)
    4.3 Europe 23-valent Pneumococcal Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific 23-valent Pneumococcal Vaccine Consumption Value (2019-2030)
    4.5 South America 23-valent Pneumococcal Vaccine Consumption Value (2019-2030)
    4.6 Middle East and Africa 23-valent Pneumococcal Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global 23-valent Pneumococcal Vaccine Consumption Value by Type (2019-2030)
    5.3 Global 23-valent Pneumococcal Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global 23-valent Pneumococcal Vaccine Consumption Value by Application (2019-2030)
    6.3 Global 23-valent Pneumococcal Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America 23-valent Pneumococcal Vaccine Market Size by Country
        7.3.1 North America 23-valent Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America 23-valent Pneumococcal Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe 23-valent Pneumococcal Vaccine Market Size by Country
        8.3.1 Europe 23-valent Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe 23-valent Pneumococcal Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific 23-valent Pneumococcal Vaccine Market Size by Region
        9.3.1 Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific 23-valent Pneumococcal Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America 23-valent Pneumococcal Vaccine Market Size by Country
        10.3.1 South America 23-valent Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America 23-valent Pneumococcal Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa 23-valent Pneumococcal Vaccine Market Size by Country
        11.3.1 Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa 23-valent Pneumococcal Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 23-valent Pneumococcal Vaccine Market Drivers
    12.2 23-valent Pneumococcal Vaccine Market Restraints
    12.3 23-valent Pneumococcal Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of 23-valent Pneumococcal Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of 23-valent Pneumococcal Vaccine
    13.3 23-valent Pneumococcal Vaccine Production Process
    13.4 23-valent Pneumococcal Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 23-valent Pneumococcal Vaccine Typical Distributors
    14.3 23-valent Pneumococcal Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global 23-valent Pneumococcal Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global 23-valent Pneumococcal Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Merck Basic Information, Manufacturing Base and Competitors
    Table 4. Merck Major Business
    Table 5. Merck 23-valent Pneumococcal Vaccine Product and Services
    Table 6. Merck 23-valent Pneumococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Merck Recent Developments/Updates
    Table 8. Sanofipasteur Basic Information, Manufacturing Base and Competitors
    Table 9. Sanofipasteur Major Business
    Table 10. Sanofipasteur 23-valent Pneumococcal Vaccine Product and Services
    Table 11. Sanofipasteur 23-valent Pneumococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Sanofipasteur Recent Developments/Updates
    Table 13. CDIBP Basic Information, Manufacturing Base and Competitors
    Table 14. CDIBP Major Business
    Table 15. CDIBP 23-valent Pneumococcal Vaccine Product and Services
    Table 16. CDIBP 23-valent Pneumococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. CDIBP Recent Developments/Updates
    Table 18. Kexing Bio Basic Information, Manufacturing Base and Competitors
    Table 19. Kexing Bio Major Business
    Table 20. Kexing Bio 23-valent Pneumococcal Vaccine Product and Services
    Table 21. Kexing Bio 23-valent Pneumococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Kexing Bio Recent Developments/Updates
    Table 23. Changsheng Bio-Technology Basic Information, Manufacturing Base and Competitors
    Table 24. Changsheng Bio-Technology Major Business
    Table 25. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product and Services
    Table 26. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Changsheng Bio-Technology Recent Developments/Updates
    Table 28. Huaan Science and Technology Innovation Basic Information, Manufacturing Base and Competitors
    Table 29. Huaan Science and Technology Innovation Major Business
    Table 30. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product and Services
    Table 31. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Huaan Science and Technology Innovation Recent Developments/Updates
    Table 33. Global 23-valent Pneumococcal Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 34. Global 23-valent Pneumococcal Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 35. Global 23-valent Pneumococcal Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 36. Market Position of Manufacturers in 23-valent Pneumococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 37. Head Office and 23-valent Pneumococcal Vaccine Production Site of Key Manufacturer
    Table 38. 23-valent Pneumococcal Vaccine Market: Company Product Type Footprint
    Table 39. 23-valent Pneumococcal Vaccine Market: Company Product Application Footprint
    Table 40. 23-valent Pneumococcal Vaccine New Market Entrants and Barriers to Market Entry
    Table 41. 23-valent Pneumococcal Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 42. Global 23-valent Pneumococcal Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 43. Global 23-valent Pneumococcal Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 44. Global 23-valent Pneumococcal Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 45. Global 23-valent Pneumococcal Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 46. Global 23-valent Pneumococcal Vaccine Average Price by Region (2019-2024) & (US$/Unit)
    Table 47. Global 23-valent Pneumococcal Vaccine Average Price by Region (2025-2030) & (US$/Unit)
    Table 48. Global 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 49. Global 23-valent Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 50. Global 23-valent Pneumococcal Vaccine Consumption Value by Type (2019-2024) & (USD Million)
    Table 51. Global 23-valent Pneumococcal Vaccine Consumption Value by Type (2025-2030) & (USD Million)
    Table 52. Global 23-valent Pneumococcal Vaccine Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. Global 23-valent Pneumococcal Vaccine Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. Global 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 55. Global 23-valent Pneumococcal Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 56. Global 23-valent Pneumococcal Vaccine Consumption Value by Application (2019-2024) & (USD Million)
    Table 57. Global 23-valent Pneumococcal Vaccine Consumption Value by Application (2025-2030) & (USD Million)
    Table 58. Global 23-valent Pneumococcal Vaccine Average Price by Application (2019-2024) & (US$/Unit)
    Table 59. Global 23-valent Pneumococcal Vaccine Average Price by Application (2025-2030) & (US$/Unit)
    Table 60. North America 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 61. North America 23-valent Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 62. North America 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 63. North America 23-valent Pneumococcal Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 64. North America 23-valent Pneumococcal Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 65. North America 23-valent Pneumococcal Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 66. North America 23-valent Pneumococcal Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 67. North America 23-valent Pneumococcal Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 68. Europe 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 69. Europe 23-valent Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 70. Europe 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 71. Europe 23-valent Pneumococcal Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 72. Europe 23-valent Pneumococcal Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 73. Europe 23-valent Pneumococcal Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 74. Europe 23-valent Pneumococcal Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 75. Europe 23-valent Pneumococcal Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 76. Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 77. Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 78. Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 79. Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 80. Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 81. Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 82. Asia-Pacific 23-valent Pneumococcal Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 83. Asia-Pacific 23-valent Pneumococcal Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 84. South America 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 85. South America 23-valent Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 86. South America 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 87. South America 23-valent Pneumococcal Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 88. South America 23-valent Pneumococcal Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 89. South America 23-valent Pneumococcal Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 90. South America 23-valent Pneumococcal Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 91. South America 23-valent Pneumococcal Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 92. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 93. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 94. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 95. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 96. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 97. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 98. Middle East & Africa 23-valent Pneumococcal Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 99. Middle East & Africa 23-valent Pneumococcal Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 100. 23-valent Pneumococcal Vaccine Raw Material
    Table 101. Key Manufacturers of 23-valent Pneumococcal Vaccine Raw Materials
    Table 102. 23-valent Pneumococcal Vaccine Typical Distributors
    Table 103. 23-valent Pneumococcal Vaccine Typical Customers
List of Figures
    Figure 1. 23-valent Pneumococcal Vaccine Picture
    Figure 2. Global 23-valent Pneumococcal Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global 23-valent Pneumococcal Vaccine Consumption Value Market Share by Type in 2023
    Figure 4. Single Dose Vial Examples
    Figure 5. Pre-filled Syringe Examples
    Figure 6. Global 23-valent Pneumococcal Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global 23-valent Pneumococcal Vaccine Consumption Value Market Share by Application in 2023
    Figure 8. Chronic Cardiovascular Disease Examples
    Figure 9. Chronic Lung Disease Examples
    Figure 10. Chronic Liver Disease Examples
    Figure 11. People Living with Hiv Examples
    Figure 12. Leukemia Examples
    Figure 13. Lymphoma Examples
    Figure 14. Multiple Myeloma Examples
    Figure 15. General Malignancy Examples
    Figure 16. Chronic Kidney Disease Examples
    Figure 17. Global 23-valent Pneumococcal Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 18. Global 23-valent Pneumococcal Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 19. Global 23-valent Pneumococcal Vaccine Sales Quantity (2019-2030) & (K Units)
    Figure 20. Global 23-valent Pneumococcal Vaccine Average Price (2019-2030) & (US$/Unit)
    Figure 21. Global 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Manufacturer in 2023
    Figure 22. Global 23-valent Pneumococcal Vaccine Consumption Value Market Share by Manufacturer in 2023
    Figure 23. Producer Shipments of 23-valent Pneumococcal Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 24. Top 3 23-valent Pneumococcal Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 25. Top 6 23-valent Pneumococcal Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 26. Global 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 27. Global 23-valent Pneumococcal Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 28. North America 23-valent Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 29. Europe 23-valent Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 30. Asia-Pacific 23-valent Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 31. South America 23-valent Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 32. Middle East & Africa 23-valent Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 33. Global 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 34. Global 23-valent Pneumococcal Vaccine Consumption Value Market Share by Type (2019-2030)
    Figure 35. Global 23-valent Pneumococcal Vaccine Average Price by Type (2019-2030) & (US$/Unit)
    Figure 36. Global 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 37. Global 23-valent Pneumococcal Vaccine Consumption Value Market Share by Application (2019-2030)
    Figure 38. Global 23-valent Pneumococcal Vaccine Average Price by Application (2019-2030) & (US$/Unit)
    Figure 39. North America 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 40. North America 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 41. North America 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 42. North America 23-valent Pneumococcal Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 43. United States 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. Canada 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. Mexico 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Europe 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 47. Europe 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 48. Europe 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 49. Europe 23-valent Pneumococcal Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 50. Germany 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. France 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 52. United Kingdom 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Russia 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Italy 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 56. Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 57. Asia-Pacific 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 58. Asia-Pacific 23-valent Pneumococcal Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 59. China 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Japan 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. Korea 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 62. India 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Southeast Asia 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Australia 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. South America 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 66. South America 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 67. South America 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 68. South America 23-valent Pneumococcal Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 69. Brazil 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Argentina 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 72. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 73. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 74. Middle East & Africa 23-valent Pneumococcal Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 75. Turkey 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 76. Egypt 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 77. Saudi Arabia 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 78. South Africa 23-valent Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 79. 23-valent Pneumococcal Vaccine Market Drivers
    Figure 80. 23-valent Pneumococcal Vaccine Market Restraints
    Figure 81. 23-valent Pneumococcal Vaccine Market Trends
    Figure 82. Porters Five Forces Analysis
    Figure 83. Manufacturing Cost Structure Analysis of 23-valent Pneumococcal Vaccine in 2023
    Figure 84. Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine
    Figure 85. 23-valent Pneumococcal Vaccine Industrial Chain
    Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 87. Direct Channel Pros & Cons
    Figure 88. Indirect Channel Pros & Cons
    Figure 89. Methodology
    Figure 90. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck
Sanofipasteur
CDIBP
Kexing Bio
Changsheng Bio-Technology
Huaan Science and Technology Innovation

Related Reports

Global 23-valent Pneumococcal Vaccine Supply, Demand and Key Producers, 2023-2029

Global 23-valent Pneumococcal Vaccine Supply, Demand and Key Producers, 2023-2029

date 28 Feb 2023

date Pharma & Healthcare

The global 23-valent Pneumococcal Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Product Tags

23-valent Pneumococcal Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>